Hye In Lee - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hye In Lee

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Journal of Cellular Physiology|July 24, 2020

Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesisYou-Jin Jo, Hye In Lee, Narae Kim, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|August 6, 2025

Refining Patient Selection for Prophylactic Cranial Irradiation in Limited-Stage SCLC: A Multicenter Cohort StudyHye In Lee, Jae Myoung Noh, Tae Hoon Lee, et al.

Free Radical Biology & Medicine|January 2, 2016

Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damageHojin Kim, Gong-Rak Lee, Jiwon Kim, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Journal of Cellular Physiology|July 24, 2020

Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesisYou-Jin Jo, Hye In Lee, Narae Kim, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|August 6, 2025

Refining Patient Selection for Prophylactic Cranial Irradiation in Limited-Stage SCLC: A Multicenter Cohort StudyHye In Lee, Jae Myoung Noh, Tae Hoon Lee, et al.

Free Radical Biology & Medicine|January 2, 2016

Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damageHojin Kim, Gong-Rak Lee, Jiwon Kim, et al.

Pageof 9